| Extracellular Vesicles and Their Roles in Cancer Progression WH Chang, RA Cerione, MA Antonyak Cancer Cell Signaling. Methods in Molecular Biology 2174, 143-170, 2021 | 102 | 2021 |
| KRAS-dependent cancer cells promote survival by producing exosomes enriched in Survivin WH Chang, TTT Nguyen, CH Hsu, KL Bryant, HJ Kim, H Ying, ... Cancer letters 517, 66-77, 2021 | 29 | 2021 |
| Rad51 facilitates filament assembly of meiosis-specific Dmc1 recombinase WH Lan, SY Lin, CY Kao, WH Chang, HY Yeh, HY Chang, P Chi, HW Li Proceedings of the National Academy of Sciences 117 (21), 11257-11264, 2020 | 26 | 2020 |
| Oncogenic RAS promotes MYC protein stability by upregulating the expression of the inhibitor of apoptosis protein (IAP) family member Survivin WH Chang, Y Liu, EA Hammes, KL Bryant, RA Cerione, MA Antonyak Journal of Biological Chemistry 299 (2), 102842, 2023 | 7 | 2023 |
| Combination of MTA-cooperative PRMT5 inhibitor and direct mutant-selective KRAS inhibitors as a novel therapeutic approach for MTAP-deficient pancreatic cancer K Drizyte-Miller, WH Chang, AM Waters, CA Stalnecker, J Wang, ... Cancer Research 84 (6_Supplement), 4588-4588, 2024 | | 2024 |
| KEAP1-NRF2 mediated resistance against KRASG12D inhibitor in pancreatic ductal adenocarcinoma WH Chang, AG Stamey, AM Waters, KL Bryant, AD Cox, CJ Der Cancer Research 84 (6_Supplement), 1936-1936, 2024 | | 2024 |
| Abstract A091: The RAF/MEK clamp avutometinib as the backbone of therapy for pancreatic cancer: Novel combinations with standard of care chemotherapy, FAK inhibitors, KRAS G12D … S Coma, X Liu, NL Pieper, WH Chang, KL Bryant, CJ Der, DG DeNardo, ... Cancer Research 84 (2_Supplement), A091-A091, 2024 | | 2024 |
| The RAF/MEK clamp avutometinib as the backbone of therapy for pancreatic cancer: Novel combinations with standard of care chemotherapy, FAK inhibitors, KRAS G12D inhibitors and … S Coma, X Liu, NL Pieper, WH Chang, KL Bryant, CJ Der, DG DeNardo, ... CANCER RESEARCH 84 (2), 2024 | | 2024 |
| Identification of resistance mechanisms to direct KRAS inhibition in pancreatic cancer AM Waters, WH Chang, C Stalnecker, C Edwards, R Yang, CM Goodwin, ... Cancer Research 83 (7_Supplement), 1075-1075, 2023 | | 2023 |
| The Important Role of Survivin in KRAS-driven Pancreatic Cancer WH Chang Cornell University, 2021 | | 2021 |
